5 Oversold Biotech Stocks to Invest In Now

Page 5 of 5

1. Enlivex Ltd. (NASDAQ:ENLV)

Price Target Upside: 2,226.93% 

Enlivex Ltd. (NASDAQ:ENLV) is one of the oversold stocks to invest in now.

TheFly reported on April 7 that H.C. Wainwright increased its price target on ENLV from $13 to $20 while maintaining a Buy rating. The firm noted that the company has completed its debt financing, which is expected to provide sufficient resources to support the ongoing clinical development of its Allocetra program.

On March 23, Enlivex Ltd. (NASDAQ:ENLV) announced that the U.S. Food and Drug Administration cleared its Investigational New Drug application for Allocetra™, an immunotherapy being developed for moderate-to-severe age-related primary knee osteoarthritis. The clearance allows the company to begin a global, randomized, double-blind, placebo-controlled Phase 2b study evaluating intra-articular injections of Allocetra in patients with the condition.

The trial is designed to assess improvements in pain, physical function, quality of life, and mobility compared with placebo at multiple time points over several months. Knee osteoarthritis affects tens of millions of patients in the United States and is expected to rise significantly over the coming decades. The company highlighted prior clinical evidence showing durable and meaningful symptom improvement lasting at least six months, particularly in older patient groups, supporting further evaluation of Allocetra as a potential treatment for this large unmet medical need.

Enlivex Ltd. (NASDAQ:ENLV) is a clinical-stage biotechnology company developing macrophage reprogramming immunotherapies, including its lead cell therapy, Allocetra, aimed at treating sepsis, osteoarthritis, and other severe inflammatory and immune-mediated diseases.

While we acknowledge the risk and potential of ENLV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ENLV and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Mid Cap Stocks to Invest In According to Billionaires and 10 Best Cheap Stocks Under $10 to Buy in April.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below

Page 5 of 5